1479-0556-7-3 1479-0556 Correction <p>Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice</p> Pacak A Christina christina.pacak@childrens.harvard.edu Sakai Yoshihisa ysakai@ufl.edu Thattaliyath D Bijoy bijoy@ufl.edu Mah S Cathryn cmah@ufl.edu Byrne J Barry bbyrne@ufl.edu

Powell Gene Therapy Center, College of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610-0266, USA

 Genetic Vaccines and Therapy 1479-0556 2009 7 1 3 http://www.gvt-journal.com/content/7/1/3 19193238 10.1186/1479-0556-7-3 28 1 2009 04 2 2009 04 2 2009 2009 Pacak et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Correction

Since publication of our article 1, it has come to our attention that the alpha-myosin heavy chain promoter was incorrectly identified as being of human origin. The correct origin of the promoter was from mouse.

The corrections within the text are as follows:

Under the heading Findings, 5 paragraph, line 3: "human alpha-myosin heavy chain" should be "murine alpha-myosin heavy chain."

Under the heading Findings, 8th paragraph, line 1: "The human a-MHC promoter" should be "The murine a-MHC promoter"

Figure 1, Figure legend, line 6; "...created by amplifying human genomic DNA" should be "... created by amplifying mouse genomic DNA."

The authors regret the error and any inconveniences to the readers. The results and conclusions of this article remain unchanged.

 <p>Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice</p> Pacak CA Sakai Y Thattaliyath BD Mah CS Byrne BJ Genetic Vaccines and Therapy 2008 6 13 10.1186/1479-0556-6-13